Drug Profile
TM 38837
Alternative Names: TM38837Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator 7TM Pharma
- Class Obesity therapies; Small molecules
- Mechanism of Action Cannabinoid receptor CB1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Obesity; Type 2 diabetes mellitus
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Obesity(In volunteers) in Denmark (PO)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Type-2-diabetes-mellitus(In volunteers) in Denmark (PO)
- 19 Apr 2013 Pharmacokinetics data from a phase I trial in healthy volunteers released by 7TM Pharma